Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2003;327:930 (18 October), doi:10.1136/bmj.327.7420.930-c
| The first 150 words of the full text of this article appear below. |
EDITORPerkins and Middleton point out that treatment of breast cancer in men may be suboptimal.1 The diagnostic work up is also a problem and not mentioned by the authors. Jobse and I recently evaluated our experience with fine needle aspiration cytology and core needle biopsy procedures in male breast lesions.2 3
Fine needle aspiration cytology had a sensitivity of 87%, a specificity of 78%, and a positive predictive value of malignancy of 100%.2 In this study a preoperative diagnosis by either aspiration cytology or core needle biopsy was not available in nine out of 28 breast carcinomas, a situation that would generally be regarded as unacceptable in women.
I reported preliminary results for core needle biopsy, but there were no false positive or false negative diagnoses, suggesting that it is a reliable preoperative procedure.3 In this study six out of 19 men did not receive a preoperative diagnosis. In
Pieter J Westenend, pathologist
Pathologisch Laboratorium voor Dordrecht eo, Laan van Londen 1800, 3317 DA Dordrecht, Netherlands pwestenend@paldordt.com